FAQ

Frequently Asked Questions

We specialize in innovative dosage formulations and Beta-lactamase Inhibitor (BLI) products that target antibiotic resistance effectively.

Yes, all of our manufacturing facilities adhere to WHO-GMP guidelines ensuring global quality standards.

We focus primarily on antibiotics, antifungals, pediatric care, and critical care injectables.

Yes, we provide high-quality contract manufacturing with end-to-end support for formulation and packaging.

We follow strict quality control protocols, validated testing methods, and regular audits in compliance with regulatory standards.

Yes, Svarny Biosciences exports products to multiple countries and is open to new global distribution partnerships.

Yes, we offer safe and easy-to-administer pediatric formulations including syrups and dispersible tablets.

You can contact our business development team via the Contact page. We’re always looking for strong partnerships globally.

Our products are manufactured under regulatory approvals from DCGI and follow international regulatory frameworks wherever applicable.

Yes, our R&D team offers formulation development services tailored to your product needs and market demands.